Revvity RVTY Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Segment revenue by Business | |||||
| Diagnostics | $1.42B+5.1% | $1.36B+5.0% | $1.29B-36.0% | $2.02B— | |
| Life Sciences | $1.43B+2.3% | $1.4B-4.1% | $1.46B+12.8% | $1.29B— | |
| Segment revenue by Geography | |||||
| Americas | $1.26B+2.7% | $1.22B+0.6% | $1.22B-26.9% | $1.66B-17.4% | |
| Asia | $775.11M-1.8% | $789.33M+0.2% | $787.94M-3.6% | $817.37M-19.3% | |
| CHINA | $425.06M-5.5% | $450.01M-1.0% | $454.43M-4.6% | $476.37M+6.0% | |
| Europe | $824.98M+11.1% | $742.61M-0.6% | $747.02M-10.2% | $831.81M-40.5% | |
| GERMANY | $177.66M+9.3% | $162.58M-15.8% | $193.17M— | —— | |
| UNITED KINGDOM | $126.85M+12.4% | $112.88M-10.0% | $125.42M-7.8% | $136.02M-62.0% | |
| UNITED STATES | $1.13B+2.6% | $1.1B-1.8% | $1.12B-27.7% | $1.55B-8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Revvity break its business down?
- Revvity (RVTY) reports segment revenue by business across 2 parts — Diagnostics and Life Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Revvity's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Revvity's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
